CLARITY-BPA Core Study: Analysis for non-monotonic dose-responses and biological relevance

Area of Science:

• Toxicology
• Endocrinology
• Environmental Health

Background:

• Bisphenol A (BPA) is a chemical with potential endocrine-disrupting properties.
• Concerns exist regarding non-monotonic dose responses (NMDR) for BPA, where effects do not follow a linear dose-dependent pattern.
• The National Toxicology Program (NTP) conducted a large-scale, 2-year rat study (CLARITY-BPA Core Study) to investigate BPA toxicity.

Purpose of the Study:

• To evaluate the 81 statistically significant findings from the CLARITY-BPA Core Study for evidence of NMDR.
• To assess whether BPA exposure in rats exhibits NMDR, particularly for endocrine-related and reproductive endpoints.

Main Methods:

• Utilized a recently published methodology with six checkpoints to assess NMDR.
• Analyzed 81 significant findings from the CLARITY-BPA Core Study, which involved oral gavage administration of BPA to rats at various doses.
• Focused on endocrine and reproductive endpoints for NMDR evaluation.

Main Results:

• Only 2 out of 81 findings met at least 5 of the NMDR checkpoints: increased basophils in stop-dose females and decreased bile acids in stop-dose males.
• These two findings lacked concordance with other BPA data.
• Crucially, no endocrine-related or reproductive endpoints met the criteria for NMDR.

Conclusions:

• The analysis indicates limited evidence for non-monotonic dose responses associated with BPA treatment in the CLARITY-BPA Core Study.
• These findings align with the conclusions presented in the original CLARITY-BPA Core Study report.
• The study suggests that BPA's toxicological profile, particularly concerning NMDR, is not strongly supported by the analyzed data.